Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting

Clinical trial NCT07124195 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07124195
Sponsor: The First Affiliated Hospital of Xinxiang Medical College
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Solid Tumors Moderate to High Emetogenic Chemotherapy (MEC/HEC) Drugs

Start date: 2025-08-10
Primary completion: 2026-10-31
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.